Cargando…
Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 Diabetes
AIMS: Although there is still no clear definition of “adipose tissue dysfunction” or ATD, the identification of a clinical marker of altered fat distribution and function may provide the needed tools for early identification of a condition of cardiometabolic risk. Our aim was to evaluate the correla...
Autores principales: | Amato, Marco C., Pizzolanti, Giuseppe, Torregrossa, Vittoria, Misiano, Gabriella, Milano, Salvatore, Giordano, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961281/ https://www.ncbi.nlm.nih.gov/pubmed/24651545 http://dx.doi.org/10.1371/journal.pone.0091969 |
Ejemplares similares
-
Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population
por: Amato, Marco C, et al.
Publicado: (2011) -
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction
por: Amato, Marco Calogero, et al.
Publicado: (2014) -
Phenotyping of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: Results of a two‐step cluster analysis
por: Amato, Marco Calogero, et al.
Publicado: (2015) -
Cardiometabolic Index (CMI) and Visceral Adiposity Index (VAI) Highlight a Higher Risk of Metabolic Syndrome in Women with Severe Obesity
por: Lazzer, Stefano, et al.
Publicado: (2023) -
Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes
por: Ahn, Nayeon, et al.
Publicado: (2019)